Literature DB >> 8937402

Influence of antibiotics on posttransfusion platelet increment.

M Böck1, K H Muggenthaler, U Schmidt, M U Heim.   

Abstract

BACKGROUND: Fever has been identified as a major cause of platelet refractoriness. However, it is regularly attended by the administration of antibiotics, and thus it cannot be determined whether fever, the administration of antibiotics, or both are responsible for the reduced platelet increment. The present study was undertaken to discern the effect of body temperature and antibiotics on transfusion success. STUDY DESIGN AND METHODS: Single-donor platelet transfusions (n = 400) were monitored retrospectively. Besides other influencing factors (e.g., spleen size, number of previous transfusions, diagnosis, bone marrow transplantation), body temperature and the administration of antibiotics were documented from the patients' records. To distinguish the effects of fever and antibiotics, a general mixed model of variance was used for analysis.
RESULTS: Besides the well-known factors of splenomegaly, hepatomegaly, bone marrow transplantation, and pretransfusion storage time, both body temperature and antibiotics independently reduced the corrected count increment. Among the various antibiotics, amphotericin B, ciprofloxacin, and vancomycin had the greatest influence.
CONCLUSION: The administration of antibiotics has a negative effect on the corrected count increment, independent of the presence of fever. Besides amphotericin B, which has previously been shown to influence the corrected count increment, vancomycin and ciprofloxacin reduce it significantly. Because these antibiotics are widely used in patients with bone marrow failure, these observations should be proven by further prospective in vivo and in vitro studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8937402     DOI: 10.1046/j.1537-2995.1996.36111297091736.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Detection and Identification of Platelet-Associated Alloantibodies by a Solid-Phase Modified Antigen Capture Elisa (MACE) Technique and Its Correlation to Platelet Refractoriness in Multi platelet Concentrate Transfused Patients.

Authors:  R S Sarkar; J Philip; Neelesh Jain
Journal:  Indian J Hematol Blood Transfus       Date:  2014-03-29       Impact factor: 0.900

2.  Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.

Authors:  Ravindra P Singh; Neelam Marwaha; Pankaj Malhotra; Sumitra Dash
Journal:  Asian J Transfus Sci       Date:  2009-07

3.  Retrospective cohort studies of repeat donors reveal donor-dependent variability in the recovery of transfused platelets.

Authors:  Jonathan A Stefely; Michael Gailey; Michael Knudson; Larry J Dumont; Thomas J Raife; Noelle I Samia
Journal:  Transfusion       Date:  2020-06-01       Impact factor: 3.157

4.  Platelet Defects in Acute Myeloid Leukemia-Potential for Hemorrhagic Events.

Authors:  Horia Bumbea; Ana Maria Vladareanu; Ion Dumitru; Viola Maria Popov; Cristina Ciufu; Anca Nicolescu; Minodora Onisai; Cristina Marinescu; Diana Cisleanu; Irina Voican; Sinziana Sarghi
Journal:  J Clin Med       Date:  2021-12-26       Impact factor: 4.241

5.  Applicability of an instrument to identify human leukocyte antigen-compatible donors for platelet transfusions.

Authors:  Millena Gomes Ferreira; Fernanda Bernadelli De Vito; Aline Aparecida Ferreira; Carolina Bonet Bub; Fernando Antônio Vinhal Dos Santos; Adilson Botelho Filho; Sheila Soares Silva; Helio Moraes-Souza
Journal:  Hematol Transfus Cell Ther       Date:  2018-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.